
The Motley Fool Investing Philosophy: We generally recommend investors buy shares of at least 25 stocks and hold them for at least 5 years. Learn More
| 1 Year | 5 Year | 5 Year Annualized | Since IPO | |
|---|---|---|---|---|
| DSS | +7.72% | -99.22% | -62.15% | -100% |
| S&P | +11.09% | +81.2% | +12.62% | +356% |
DSS, Inc. engages in the development and distribution of paper products designed to protect valuable information from unauthorized scanning, copying, and digital imaging. It operates through the following segments: Product Packaging, Commercial Lending, Biotechnology, Direct Marketing, and Securities and Investment Management. The Product Packaging segment operates in the paper board folding carton, smart packaging, and document security printing markets. The Commercial Lending segment provides commercial loans and on acquiring equity positions in undervalued commercial bank(s), bank holding companies and non-banking licensed financial companies operating in the United States, Southeast Asia, Taiwan, Japan, and South Korea. The Biotechnology segment invests in or acquires companies in the bio-health and biomedical fields, including businesses focused on the advancement of drug discovery and prevention, inhibition, and treatment of neurological, oncological, and immune related diseases. The Direct Marketing segment provides services to assist companies in the emerging growth gig business model of peer-to-peer decentralized sharing marketplaces. The Securities and Investment Management segment develops and/or acquire assets and investments in the securities trading and/or funds management arena and to pursue, among other product and service lines, real estate investment funds, broker dealers and mutual funds management. The company was founded on June 16, 1984 and is headquartered in West Henrietta, NY.
No news articles found for Dss.
| Q3 2025 | YOY Change | |
|---|---|---|
| Revenue | $6.39M | 14.2% |
| Gross Profit | $324.00K | 132.3% |
| Gross Margin | 5.07% | 23.0% |
| Market Cap | $12.27M | 36.8% |
| Market Cap / Employee | $122.75K | 0.0% |
| Employees | 100 | 5.3% |
| Net Income | -$2,229.00K | 60.9% |
| EBITDA | -$2,147.00K | 54.1% |
Currently no data to display
Currently no data to display.
Currently no data to display.
| Q3 2025 | YOY Change | |
|---|---|---|
| Net Cash | $7.12M | -38.8% |
| Accounts Receivable | $4.60M | -23.6% |
| Inventory | 2.9 | -13.2% |
| Q3 2025 | YOY Change | |
|---|---|---|
| Long Term Debt | $11.82M | -14.9% |
| Short Term Debt | $44.86M | -11.2% |
| Q3 2025 | YOY Change | |
|---|---|---|
| Return On Assets | -35.85% | -9.7% |
| Return On Invested Capital | -57.93% | -22.9% |
| Q3 2025 | YOY Change | |
|---|---|---|
| Free Cash Flow | -$8,088.00K | -124.2% |
| Operating Free Cash Flow | -$8,006.00K | -122.0% |
| Metric | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | YoY Change |
|---|---|---|---|---|---|
| Price to Book | 0.12 | 0.12 | 0.48 | 0.78 | 422.62% |
| Price to Sales | 0.33 | 0.37 | 0.40 | 0.56 | 28.38% |
| Price to Tangible Book Value | 1.05 | 1.01 | -3.46 | -3.28 | -580.33% |
| Enterprise Value to EBITDA | -2.34 | -20.15 | -22.20 | -33.57 | 97.98% |
| Return on Equity | -111.4% | -122.5% | -127.3% | -126.9% | 109.56% |
| Total Debt | $64.10M | $56.04M | $56.36M | $56.68M | -12.00% |
No podcast episodes available.
No transcripts available.
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.